Should Medicare and Medicaid eventually cover new weight loss drugs such as Ozempic and Wegovy? This week, Audacy took a look ...

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...

As of late 2024, only 14 state Medicaid programs cover GLP-1 drugs like Wegovy, Saxenda, or Zepbound for the treatment of obesity. These states are: California, Connecticut, Indiana, Maryland, ...

The Trump administration announced it will not finalize a rule proposed by the Biden administration that would have allowed ...

Trump signs executive order, discussed "overweight" friend who was taking the "fat shot drug." It wasn't confirmed whether he ...

Patients taking Eli Lilly’s drug to combat obesity, Zepbound, lost more weight than those who took Novo Nordisk’s Wegovy in a ...

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The Trump plan won't be limited to Medicare prescriptions and will also target medications covered by Medicaid and private ...

"So this is not just the weight loss, it's also health indicators ... under Biden to expand coverage to these drugs under Medicare, the Trump administration pulled back on that, and a lot ...